{"symbol": "ICPT", "companyName": "Intercept Pharmaceuticals Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.interceptpharma.com", "description": "Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.", "CEO": "Mark Pruzanski", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}